Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q43073586
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000219.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q43073586
|
024
|
|
|
‡a
0000-0001-7342-8348
‡2
orcid
|
024
|
|
|
‡a
7006024634
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q43073586
|
100
|
0 |
|
‡a
Andrew Taylor-Robinson
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Andrew Taylor-Robinson
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A Co-infection model of malaria and hepatitis B virus. Pasquetto, V. et al. (2000) host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J. Exp. Med. 192, 529-536
|
670
|
|
|
‡a
Author's A comparative analysis of the efficacy of three cryopreservation protocols on the survival of in vitro-derived cattle embryos at pronuclear and blastocyst stages
|
670
|
|
|
‡a
Author's A dichotomous role for nitric oxide in protection against blood stage malaria infection
|
670
|
|
|
‡a
Author's A model of development of acquired immunity to malaria in humans living under endemic conditions
|
670
|
|
|
‡a
Author's A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.
|
670
|
|
|
‡a
Author's A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
|
670
|
|
|
‡a
Author's An in vitro assessment of the value of sucrose supplementation to warming media for the vitrification of bovine embryos
|
670
|
|
|
‡a
Author's Anti-malarial antibodies in twins
|
670
|
|
|
‡a
Author's Are antibodies important in mice infected with Plasmodium yoelii?
|
670
|
|
|
‡a
Author's Are nitric oxide, malaria crisis form factor and malaria paroxysm factor, one and the same?
|
670
|
|
|
‡a
Author's Biology of malarial liver stages: implications for vaccine design
|
670
|
|
|
‡a
Author's Book Review—Immunology of Infectious Diseases.
|
670
|
|
|
‡a
Author's Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia
|
670
|
|
|
‡a
Author's Comparison of pregnancy in cattle when non-vitrified and vitrified in vitro-derived embryos are transferred into recipients
|
670
|
|
|
‡a
Author's Confronting the Emerging Threat to Public Health in Northern Australia of Neglected Indigenous Arboviruses
|
670
|
|
|
‡a
Author's Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2.
|
670
|
|
|
‡a
Author's COVID-19: Cultural Predictors of Gender Differences in Global Prevalence Patterns
|
670
|
|
|
‡a
Author's Cultivation of Plasmodium falciparum in vitro using microbiological gas sachets that generate microaerophilic conditions.
|
670
|
|
|
‡a
Author's Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
|
670
|
|
|
‡a
Author's Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.
|
670
|
|
|
‡a
Author's Describing Chronic Malaria Infections
|
670
|
|
|
‡a
Author's Do neglected Australian arboviruses pose a global epidemic threat?
|
670
|
|
|
‡a
Author's Emerging and re-emerging bacterial zoonoses in Nigeria: current preventive measures and future approaches to intervention
|
670
|
|
|
‡a
Author's Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
|
670
|
|
|
‡a
Author's Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids
|
670
|
|
|
‡a
Author's Expression of the IL-1 receptor discriminates Th2 from Th1 cloned CD4+ T cells specific for Plasmodium chabaudi.
|
670
|
|
|
‡a
Author's Glomerulonephritis and nephrotic syndrome in Plasmodium chabaudi chabaudi: a potential murine model of chronic P. malariae infection.
|
670
|
|
|
‡a
Author's Heterologous gene expression in bacterial systems under reduced oxygen tensions. Small-scale optimization precedes industrial fermentation
|
670
|
|
|
‡a
Author's Identification of the source of blood meals in mosquitoes collected from north-eastern Australia
|
670
|
|
|
‡a
Author's Immunity to asexual blood stages of: is resistance to acute malaria adaptive or innate? - a response.
|
670
|
|
|
‡a
Author's Immunity to liver stage malaria: considerations for vaccine design.
|
670
|
|
|
‡a
Author's Improving Accuracy of Malaria Diagnosis in Underserved Rural and Remote Endemic Areas of Sub-Saharan Africa: A Call to Develop Multiplexing Rapid Diagnostic Tests
|
670
|
|
|
‡a
Author's In-vitro model offers insight into the pathophysiology of severe malaria
|
670
|
|
|
‡a
Author's Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection
|
670
|
|
|
‡a
Author's Infection of Western Gray Kangaroos (Macropus fuliginosus) with Australian Arboviruses Associated with Human Infection
|
670
|
|
|
‡a
Author's Infectious Disease Surveillance in Vietnam: Pathogen Early Detection in Hanoi Wastewater
|
670
|
|
|
‡a
Author's Infective dose modulates the balance between Th1- and Th2-regulated immune responses during blood-stage malaria infection
|
670
|
|
|
‡a
Author's Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation.
|
670
|
|
|
‡a
Author's Knowledge, attitude and recommendations for practice regarding dengue among the resident population of Queensland, Australia
|
670
|
|
|
‡a
Author's Long-term predictors of dengue outbreaks in Bangladesh: A data mining approach
|
670
|
|
|
‡a
Author's Major shift in national health policy towards poliomyelitis in Pakistan reaps rewards
|
670
|
|
|
‡a
Author's Malaria in Sri Lanka: Investigating causes of the recent elimination and making plans to prevent reintroduction
|
670
|
|
|
‡a
Author's Malaria-specific IgE as a risk factor for cancer and atopy.
|
670
|
|
|
‡a
Author's Missing malaria? Potential obstacles to diagnosis and hypnozoite eradication
|
670
|
|
|
‡a
Author's Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway
|
670
|
|
|
‡a
Author's Multiple vaccination effects on atopy
|
670
|
|
|
‡a
Author's Murine models of cerebral malaria: a qualified defence
|
670
|
|
|
‡a
Author's Naturally acquired versus vaccine-induced immunity to malaria: a dual role for TGF-beta and IL-12?
|
670
|
|
|
‡a
Author's Neglected Australian Arboviruses and Undifferentiated Febrile Illness: Addressing Public Health Challenges Arising From the 'Developing Northern Australia' Government Policy.
|
670
|
|
|
‡a
Author's Neglected Australian Arboviruses Associated With Undifferentiated Febrile Illnesses
|
670
|
|
|
‡a
Author's Neglected Australian arboviruses: quam gravis?
|
670
|
|
|
‡a
Author's New episode of Middle East Respiratory Syndrome Coronavirus outbreak in Saudi Arabia: an emerging public health threat
|
670
|
|
|
‡a
Author's Nitric oxide in malaria: Indicator of disease severity and infection control
|
670
|
|
|
‡a
Author's Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections
|
670
|
|
|
‡a
Author's Population migration and malaria: terms of reference
|
670
|
|
|
‡a
Author's Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen
|
670
|
|
|
‡a
Author's Predominance of infected reticulocytes in the peripheral blood of CD4+ T-cell-depleted mice chronically infected with Plasmodium chabaudi chabaudi
|
670
|
|
|
‡a
Author's Regulation of immunity to malaria: valuable lessons learned from murine models
|
670
|
|
|
‡a
Author's Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.
|
670
|
|
|
‡a
Author's Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
|
670
|
|
|
‡a
Author's Regulatory T lymphocytes are associated with increased nasopharyngeal colonization in children
|
670
|
|
|
‡a
Author's RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation
|
670
|
|
|
‡a
Author's Sensitivity of malaria parasites to nitric oxide at low oxygen tensions
|
670
|
|
|
‡a
Author's Species-transcending regulation of malaria parasitaemia
|
670
|
|
|
‡a
Author's Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection
|
670
|
|
|
‡a
Author's The epidemiology of dengue infection: Harnessing past experience and current knowledge to support implementation of future control strategies.
|
670
|
|
|
‡a
Author's The global spread of Zika virus: is public and media concern justified in regions currently unaffected?
|
670
|
|
|
‡a
Author's The 'lifecycle' of human beings: a call to explore vector-borne diseases from an ecosystem perspective
|
670
|
|
|
‡a
Author's The potential for modification in cloning and vitrification technology to enhance genetic progress in beef cattle in Northern Australia
|
670
|
|
|
‡a
Author's The role of TH1 and TH2 cells in a rodent malaria infection.
|
670
|
|
|
‡a
Author's The sequestration hypothesis: an explanation for the sensitivity of malaria parasites to nitric oxide-mediated immune effector function in vivo
|
670
|
|
|
‡a
Author's Tomatine adjuvantation of protective immunity to a major pre-erythrocytic vaccine candidate of malaria is mediated via CD8+ T cell release of IFN-gamma
|
670
|
|
|
‡a
Author's Vaccine myopia: adult vaccination also needs attention
|
670
|
|
|
‡a
Author's Validity of malaria models: need for a less circular, more secular, argument
|
670
|
|
|
‡a
Author's Vitrification of in vitro-derived bovine embryos: targeting enhancement of quality by refining technology and standardising procedures
|
909
|
|
|
‡a
(scopus) 7006024634
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000173428348
‡9
1
|
919
|
|
|
‡a
comparisonofpregnancyincattlewhennonvitrifiedandvitrifiedinvitroderivedembryosaretransferredintorecipients
‡A
Comparison of pregnancy in cattle when non-vitrified and vitrified in vitro-derived embryos are transferred into recipients
‡9
1
|
919
|
|
|
‡a
malariainsrilankainvestigatingcausesoftherecenteliminationandmakingplanstopreventreintroduction
‡A
Malaria in Sri Lanka: Investigating causes of the recent elimination and making plans to prevent reintroduction
‡9
1
|
919
|
|
|
‡a
knowledgeattitudeandrecommendationsforpracticeregardingdengueamongtheresidentpopulationofqueenslandaustralia
‡A
Knowledge, attitude and recommendations for practice regarding dengue among the resident population of Queensland, Australia
‡9
1
|
919
|
|
|
‡a
longtermpredictorsofdengueoutbreaksinbangladeshadataminingapproach
‡A
Long-term predictors of dengue outbreaks in Bangladesh: A data mining approach
‡9
1
|
919
|
|
|
‡a
describingchronicmalariainfections
‡A
Describing Chronic Malaria Infections
‡9
1
|
919
|
|
|
‡a
lifecycleofhumanbeingsacalltoexplorevectorbornediseasesfromanecosystemperspective
‡A
The 'lifecycle' of human beings: a call to explore vector-borne diseases from an ecosystem perspective
‡9
1
|
919
|
|
|
‡a
tomatineadjuvantationofprotectiveimmunitytoamajorpreerythrocyticvaccinecandidateofmalariaismediatedviacd8+tcellreleaseofifngamma
‡A
Tomatine adjuvantation of protective immunity to a major pre-erythrocytic vaccine candidate of malaria is mediated via CD8+ T cell release of IFN-gamma
‡9
1
|
919
|
|
|
‡a
immunitytoliverstagemalariaconsiderationsforvaccinedesign
‡A
Immunity to liver stage malaria: considerations for vaccine design.
‡9
1
|
919
|
|
|
‡a
potentialformodificationincloningandvitrificationtechnologytoenhancegeneticprogressinbeefcattleinnorthernaustralia
‡A
The potential for modification in cloning and vitrification technology to enhance genetic progress in beef cattle in Northern Australia
‡9
1
|
919
|
|
|
‡a
improvingaccuracyofmalariadiagnosisinunderservedruralandremoteendemicareasofsubsaharanafricaacalltodevelopmultiplexingrapiddiagnostictests
‡A
Improving Accuracy of Malaria Diagnosis in Underserved Rural and Remote Endemic Areas of Sub-Saharan Africa: A Call to Develop Multiplexing Rapid Diagnostic Tests
‡9
1
|
919
|
|
|
‡a
missingmalariapotentialobstaclestodiagnosisandhypnozoiteeradication
‡A
Missing malaria? Potential obstacles to diagnosis and hypnozoite eradication
‡9
1
|
919
|
|
|
‡a
vaccinemyopiaadultvaccinationalsoneedsattention
‡A
Vaccine myopia: adult vaccination also needs attention
‡9
1
|
919
|
|
|
‡a
malariaspecificigeasariskfactorforcancerandatopy
‡A
Malaria-specific IgE as a risk factor for cancer and atopy.
‡9
1
|
919
|
|
|
‡a
validityofmalariamodelsneedforalesscircularmoresecularargument
‡A
Validity of malaria models: need for a less circular, more secular, argument
‡9
1
|
919
|
|
|
‡a
sensitivityofmalariaparasitestonitricoxideatlowoxygentensions
‡A
Sensitivity of malaria parasites to nitric oxide at low oxygen tensions
‡9
1
|
919
|
|
|
‡a
vitrificationofinvitroderivedbovineembryostargetingenhancementofqualitybyrefiningtechnologyandstandardisingprocedures
‡A
Vitrification of in vitro-derived bovine embryos: targeting enhancement of quality by refining technology and standardising procedures
‡9
1
|
919
|
|
|
‡a
increasedproductionofacutephaseproteinscorrespondstothepeakparasitaemiaofprimarymalariainfection
‡A
Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection
‡9
1
|
919
|
|
|
‡a
dengueepidemiologyandpathogenesisimagesofthefutureviewedthroughamirrorofthepast
‡A
Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.
‡9
1
|
919
|
|
|
‡a
decodingtheenigmaofantiviralcrisisdoes1targetmoleculeregulateall
‡A
Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
‡9
1
|
919
|
|
|
‡a
cultivationofplasmodiumfalciparuminvitrousingmicrobiologicalgassachetsthatgeneratemicroaerophilicconditions
‡A
Cultivation of Plasmodium falciparum in vitro using microbiological gas sachets that generate microaerophilic conditions.
‡9
1
|
919
|
|
|
‡a
roleofth1andth2cellsinarodentmalariainfection
‡A
The role of TH1 and TH2 cells in a rodent malaria infection.
‡9
1
|
919
|
|
|
‡a
covid19culturalpredictorsofgenderdifferencesinglobalprevalencepatterns
‡A
COVID-19: Cultural Predictors of Gender Differences in Global Prevalence Patterns
‡9
1
|
919
|
|
|
‡a
glomerulonephritisandnephroticsyndromeinplasmodiumchabaudichabaudiapotentialmurinemodelofchronicpmalariaeinfection
‡A
Glomerulonephritis and nephrotic syndrome in Plasmodium chabaudi chabaudi: a potential murine model of chronic P. malariae infection.
‡9
1
|
919
|
|
|
‡a
majorshiftinnationalhealthpolicytowardspoliomyelitisinpakistanreapsrewards
‡A
Major shift in national health policy towards poliomyelitis in Pakistan reaps rewards
‡9
1
|
919
|
|
|
‡a
invitromodeloffersinsightintothepathophysiologyofseveremalaria
‡A
In-vitro model offers insight into the pathophysiology of severe malaria
‡9
1
|
919
|
|
|
‡a
sequestrationhypothesisanexplanationforthesensitivityofmalariaparasitestonitricoxidemediatedimmuneeffectorfunctioninvivo
‡A
The sequestration hypothesis: an explanation for the sensitivity of malaria parasites to nitric oxide-mediated immune effector function in vivo
‡9
1
|
919
|
|
|
‡a
identificationofthesourceofbloodmealsinmosquitoescollectedfromnortheasternaustralia
‡A
Identification of the source of blood meals in mosquitoes collected from north-eastern Australia
‡9
1
|
919
|
|
|
‡a
comparativeanalysisoftheefficacyof3cryopreservationprotocolsonthesurvivalofinvitroderivedcattleembryosatpronuclearandblastocyststages
‡A
A comparative analysis of the efficacy of three cryopreservation protocols on the survival of in vitro-derived cattle embryos at pronuclear and blastocyst stages
‡9
1
|
919
|
|
|
‡a
immunitytoasexualbloodstagesofisresistancetoacutemalariaadaptiveorinnatearesponse
‡A
Immunity to asexual blood stages of: is resistance to acute malaria adaptive or innate? - a response.
‡9
1
|
919
|
|
|
‡a
rnabacteriophagecapsidmediateddrugdeliveryandepitopepresentation
‡A
RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation
‡9
1
|
919
|
|
|
‡a
regulatorytlymphocytesareassociatedwithincreasednasopharyngealcolonizationinchildren
‡A
Regulatory T lymphocytes are associated with increased nasopharyngeal colonization in children
‡9
1
|
919
|
|
|
‡a
regulationoftheimmuneresponsebynitricoxidedifferentiallyproducedbythelpertype1andthelpertype2cells
‡A
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
‡9
1
|
919
|
|
|
‡a
regulationofimmunitytoplasmodiumimplicationsfrommousemodelsforbloodstagemalariavaccinedesign
‡A
Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.
‡9
1
|
919
|
|
|
‡a
coinfectionmodelofmalariaandhepatitisbviruspasquetto5etal2000hostvirusinteractionsduringmalariainfectioninhepatitisbvirustransgenicmicejexpmed192529536
‡A
A Co-infection model of malaria and hepatitis B virus. Pasquetto, V. et al. (2000) host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J. Exp. Med. 192, 529-536
‡9
1
|
919
|
|
|
‡a
regulationofimmunitytomalariavaluablelessonslearnedfrommurinemodels
‡A
Regulation of immunity to malaria: valuable lessons learned from murine models
‡9
1
|
919
|
|
|
‡a
predominanceofinfectedreticulocytesintheperipheralbloodofcd4+tcelldepletedmicechronicallyinfectedwithplasmodiumchabaudichabaudi
‡A
Predominance of infected reticulocytes in the peripheral blood of CD4+ T-cell-depleted mice chronically infected with Plasmodium chabaudi chabaudi
‡9
1
|
919
|
|
|
‡a
potentiationbyanovelalkaloidglycosideadjuvantofaprotectivecytotoxictcellimmuneresponsespecificforapreerythrocyticmalariavaccinecandidateantigen
‡A
Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen
‡9
1
|
919
|
|
|
‡a
populationmigrationandmalariatermsofreference
‡A
Population migration and malaria: terms of reference
‡9
1
|
919
|
|
|
‡a
modulationofexperimentalbloodstagemalariathroughblockadeoftheb7cd28tcellcostimulatorypathway
‡A
Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway
‡9
1
|
919
|
|
|
‡a
parasitespecificimmunoglobulinisotypesduringlethalandnonlethalmurinemalariainfections
‡A
Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections
‡9
1
|
919
|
|
|
‡a
bookreviewimmunologyofinfectiousdiseases
‡A
Book Review—Immunology of Infectious Diseases.
‡9
1
|
919
|
|
|
‡a
nitricoxideinmalariaindicatorofdiseaseseverityandinfectioncontrol
‡A
Nitric oxide in malaria: Indicator of disease severity and infection control
‡9
1
|
919
|
|
|
‡a
speciestranscendingregulationofmalariaparasitaemia
‡A
Species-transcending regulation of malaria parasitaemia
‡9
1
|
919
|
|
|
‡a
newepisodeofmiddleeastrespiratorysyndromecoronavirusoutbreakinsaudiarabiaanemergingpublichealththreat
‡A
New episode of Middle East Respiratory Syndrome Coronavirus outbreak in Saudi Arabia: an emerging public health threat
‡9
1
|
919
|
|
|
‡a
biologyofmalarialliverstagesimplicationsforvaccinedesign
‡A
Biology of malarial liver stages: implications for vaccine design
‡9
1
|
919
|
|
|
‡a
neglectedaustralianarbovirusesquamgravis
‡A
Neglected Australian arboviruses: quam gravis?
‡9
1
|
919
|
|
|
‡a
arenitricoxidemalariacrisisformfactorandmalariaparoxysmfactor1andthesame
‡A
Are nitric oxide, malaria crisis form factor and malaria paroxysm factor, one and the same?
‡9
1
|
919
|
|
|
‡a
roleforcytokinesinpotentiationofmalariavaccinesthroughimmunologicalmodulationofbloodstageinfection
‡A
A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.
‡9
1
|
919
|
|
|
‡a
heterologousgeneexpressioninbacterialsystemsunderreducedoxygentensionssmallscaleoptimizationprecedesindustrialfermentation
‡A
Heterologous gene expression in bacterial systems under reduced oxygen tensions. Small-scale optimization precedes industrial fermentation
‡9
1
|
919
|
|
|
‡a
th1andth2cd4+tcellclonesspecificforplasmodiumchabaudibutnotforanunrelatedantigenprotectagainstbloodstagepchabaudiinfection
‡A
Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection
‡9
1
|
919
|
|
|
‡a
vaccineeffectiveagainstzikavirusistheoreticallypossiblebutmaynotbedeliveredanytimesoon
‡A
A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
‡9
1
|
919
|
|
|
‡a
expressionoftheil1receptordiscriminatesth2fromth1clonedcd4+tcellsspecificforplasmodiumchabaudi
‡A
Expression of the IL-1 receptor discriminates Th2 from Th1 cloned CD4+ T cells specific for Plasmodium chabaudi.
‡9
1
|
919
|
|
|
‡a
neglectedaustralianarbovirusesassociatedwithundifferentiatedfebrileillnesses
‡A
Neglected Australian Arboviruses Associated With Undifferentiated Febrile Illnesses
‡9
1
|
919
|
|
|
‡a
murinemodelsofcerebralmalariaaqualifieddefence
‡A
Murine models of cerebral malaria: a qualified defence
‡9
1
|
919
|
|
|
‡a
expressionandimmunogenicityofaliverstagemalariaepitopepresentedasaforeignpeptideonthesurfaceofrnafreems2bacteriophagecapsids
‡A
Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids
‡9
1
|
919
|
|
|
‡a
exoerythrocyticmalariavaccinedevelopmentunderstandinghostparasiteimmunobiologyunderscoresstrategicsuccess
‡A
Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.
‡9
1
|
919
|
|
|
‡a
epidemiologyofdengueinfectionharnessingpastexperienceandcurrentknowledgetosupportimplementationoffuturecontrolstrategies
‡A
The epidemiology of dengue infection: Harnessing past experience and current knowledge to support implementation of future control strategies.
‡9
1
|
919
|
|
|
‡a
modelofdevelopmentofacquiredimmunitytomalariainhumanslivingunderendemicconditions
‡A
A model of development of acquired immunity to malaria in humans living under endemic conditions
‡9
1
|
919
|
|
|
‡a
invitroassessmentofthevalueofsucrosesupplementationtowarmingmediaforthevitrificationofbovineembryos
‡A
An in vitro assessment of the value of sucrose supplementation to warming media for the vitrification of bovine embryos
‡9
1
|
919
|
|
|
‡a
antimalarialantibodiesintwins
‡A
Anti-malarial antibodies in twins
‡9
1
|
919
|
|
|
‡a
neglectedaustralianarbovirusesandundifferentiatedfebrileillnessaddressingpublichealthchallengesarisingfromthedevelopingnorthernaustraliagovernmentpolicy
‡A
Neglected Australian Arboviruses and Undifferentiated Febrile Illness: Addressing Public Health Challenges Arising From the 'Developing Northern Australia' Government Policy.
‡9
1
|
919
|
|
|
‡a
naturallyacquiredversusvaccineinducedimmunitytomalariaadualrolefortgfbetaandil12
‡A
Naturally acquired versus vaccine-induced immunity to malaria: a dual role for TGF-beta and IL-12?
‡9
1
|
919
|
|
|
‡a
multiplevaccinationeffectsonatopy
‡A
Multiple vaccination effects on atopy
‡9
1
|
919
|
|
|
‡a
areantibodiesimportantinmiceinfectedwithplasmodiumyoelii
‡A
Are antibodies important in mice infected with Plasmodium yoelii?
‡9
1
|
919
|
|
|
‡a
counterregulationofthelper1cellproliferationbynitricoxideandinterleukin2
‡A
Counter-regulation of T helper 1 cell proliferation by nitric oxide and interleukin-2.
‡9
1
|
919
|
|
|
‡a
dichotomousrolefornitricoxideinprotectionagainstbloodstagemalariainfection
‡A
A dichotomous role for nitric oxide in protection against blood stage malaria infection
‡9
1
|
919
|
|
|
‡a
infectionofwesterngraykangaroosmacropusfuliginosuswithaustralianarbovirusesassociatedwithhumaninfection
‡A
Infection of Western Gray Kangaroos (Macropus fuliginosus) with Australian Arboviruses Associated with Human Infection
‡9
1
|
919
|
|
|
‡a
infectiousdiseasesurveillanceinvietnampathogenearlydetectioninhanoiwastewater
‡A
Infectious Disease Surveillance in Vietnam: Pathogen Early Detection in Hanoi Wastewater
‡9
1
|
919
|
|
|
‡a
globalspreadofzikavirusispublicandmediaconcernjustifiedinregionscurrentlyunaffected
‡A
The global spread of Zika virus: is public and media concern justified in regions currently unaffected?
‡9
1
|
919
|
|
|
‡a
infectivedosemodulatesthebalancebetweenth1andth2regulatedimmuneresponsesduringbloodstagemalariainfection
‡A
Infective dose modulates the balance between Th1- and Th2-regulated immune responses during blood-stage malaria infection
‡9
1
|
919
|
|
|
‡a
confrontingtheemergingthreattopublichealthinnorthernaustraliaofneglectedindigenousarboviruses
‡A
Confronting the Emerging Threat to Public Health in Northern Australia of Neglected Indigenous Arboviruses
‡9
1
|
919
|
|
|
‡a
inhibitionofil2productionbynitricoxideanovelselfregulatorymechanismforth1cellproliferation
‡A
Inhibition of IL-2 production by nitric oxide: a novel self-regulatory mechanism for Th1 cell proliferation.
‡9
1
|
919
|
|
|
‡a
emergingandreemergingbacterialzoonosesinnigeriacurrentpreventivemeasuresandfutureapproachestointervention
‡A
Emerging and re-emerging bacterial zoonoses in Nigeria: current preventive measures and future approaches to intervention
‡9
1
|
919
|
|
|
‡a
doneglectedaustralianarbovirusesposeaglobalepidemicthreat
‡A
Do neglected Australian arboviruses pose a global epidemic threat?
‡9
1
|
919
|
|
|
‡a
clinicalandgeneticriskfactorsfornewonsetdiabetesmellitusaftertransplantationnodatinmajortransplantcentresinmalaysia
‡A
Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BNE|XX6076684
|
996
|
|
|
‡2
SUDOC|249304805
|
996
|
|
|
‡2
BNE|XX865501
|
996
|
|
|
‡2
BIBSYS|3082211
|
996
|
|
|
‡2
J9U|987007340118205171
|
996
|
|
|
‡2
LC|n 87134359
|
996
|
|
|
‡2
LC|no2014169088
|
996
|
|
|
‡2
SUDOC|156466058
|
996
|
|
|
‡2
NTA|074749943
|
996
|
|
|
‡2
NII|DA01652991
|
996
|
|
|
‡2
BNE|XX1091170
|
996
|
|
|
‡2
ISNI|0000000033709631
|
996
|
|
|
‡2
SUDOC|139133798
|
996
|
|
|
‡2
LC|n 85814852
|
996
|
|
|
‡2
BIBSYS|12003148
|
996
|
|
|
‡2
LNB|LNC10-000246422
|
996
|
|
|
‡2
LC|n 94014176
|
996
|
|
|
‡2
RERO|A021765320
|
996
|
|
|
‡2
NUKAT|n 96024414
|
996
|
|
|
‡2
CAOONL|ncf10317783
|
996
|
|
|
‡2
LC|no2007083913
|
996
|
|
|
‡2
LC|n 80083413
|
996
|
|
|
‡2
LC|n 2022013676
|
996
|
|
|
‡2
BNC|981058524260606706
|
996
|
|
|
‡2
LC|no2014074322
|
996
|
|
|
‡2
J9U|987007322375505171
|
996
|
|
|
‡2
ISNI|0000000388850722
|
996
|
|
|
‡2
LC|n 96022068
|
996
|
|
|
‡2
LC|nb2010002852
|
996
|
|
|
‡2
LC|no2011195452
|
996
|
|
|
‡2
NTA|173892523
|
996
|
|
|
‡2
NUKAT|n 2015136420
|
996
|
|
|
‡2
NTA|070789517
|
996
|
|
|
‡2
NSK|000550071
|
996
|
|
|
‡2
SUDOC|117435074
|
996
|
|
|
‡2
LC|nb2003091867
|
996
|
|
|
‡2
N6I|vtls000027971
|
996
|
|
|
‡2
CAOONL|ncf12139312
|
996
|
|
|
‡2
CAOONL|ncf13730382
|
996
|
|
|
‡2
LC|n 90614712
|
996
|
|
|
‡2
RERO|A011029115
|
996
|
|
|
‡2
NUKAT|n 2016231373
|
996
|
|
|
‡2
ISNI|0000000025255289
|
996
|
|
|
‡2
BIBSYS|90676987
|
996
|
|
|
‡2
SELIBR|2g5lb11m0fbfjt82
|
996
|
|
|
‡2
CAOONL|ncf11538701
|
996
|
|
|
‡2
NTA|071570381
|
996
|
|
|
‡2
LC|n 00000584
|
996
|
|
|
‡2
ISNI|0000000118755055
|
996
|
|
|
‡2
ISNI|0000000118752946
|
996
|
|
|
‡2
DNB|172347130
|
996
|
|
|
‡2
LC|n 2017070929
|
996
|
|
|
‡2
CAOONL|ncf11071209
|
996
|
|
|
‡2
LC|n 84145722
|
996
|
|
|
‡2
NUKAT|n 2016077494
|
996
|
|
|
‡2
LC|n 94802980
|
996
|
|
|
‡2
ISNI|0000000497947670
|
996
|
|
|
‡2
LC|no2020123655
|
996
|
|
|
‡2
LC|n 88051970
|
996
|
|
|
‡2
ISNI|0000000049198952
|
996
|
|
|
‡2
DNB|113727249X
|
996
|
|
|
‡2
LC|n 85225435
|
996
|
|
|
‡2
SUDOC|03089476X
|
996
|
|
|
‡2
XA|12854
|
996
|
|
|
‡2
LC|nb2010006798
|
996
|
|
|
‡2
LC|n 85064118
|
996
|
|
|
‡2
BNF|12373499
|
996
|
|
|
‡2
ISNI|0000000456017928
|
996
|
|
|
‡2
NUKAT|n 00097587
|
996
|
|
|
‡2
BIBSYS|62406
|
996
|
|
|
‡2
ISNI|0000000500789360
|
996
|
|
|
‡2
PLWABN|9810695593705606
|
996
|
|
|
‡2
PTBNP|1669548
|
996
|
|
|
‡2
RERO|A023999474
|
996
|
|
|
‡2
J9U|987007429089505171
|
996
|
|
|
‡2
DNB|1089381220
|
996
|
|
|
‡2
BIBSYS|90053461
|
996
|
|
|
‡2
LC|n 2004021175
|
996
|
|
|
‡2
LC|n 2005067085
|
996
|
|
|
‡2
BNE|XX1155732
|
996
|
|
|
‡2
ISNI|0000000036689525
|
996
|
|
|
‡2
ISNI|0000000025582853
|
996
|
|
|
‡2
ISNI|000000011971591X
|
996
|
|
|
‡2
LC|n 92104266
|
996
|
|
|
‡2
BIBSYS|11011277
|
996
|
|
|
‡2
DNB|136679455
|
996
|
|
|
‡2
J9U|987007419582105171
|
996
|
|
|
‡2
ISNI|0000000036137800
|
996
|
|
|
‡2
LC|no 98062060
|
996
|
|
|
‡2
LC|no2016069662
|
996
|
|
|
‡2
BIBSYS|90232199
|
996
|
|
|
‡2
NII|DA08556078
|
996
|
|
|
‡2
ISNI|0000000076907849
|
996
|
|
|
‡2
LC|n 85073604
|
996
|
|
|
‡2
ISNI|0000000029347738
|
996
|
|
|
‡2
CAOONL|ncf11609913
|
996
|
|
|
‡2
PTBNP|249762
|
996
|
|
|
‡2
BNF|12248031
|
996
|
|
|
‡2
LC|n 2012013877
|
996
|
|
|
‡2
SUDOC|250987147
|
996
|
|
|
‡2
LC|n 91124920
|
996
|
|
|
‡2
NUKAT|n 2015141432
|
996
|
|
|
‡2
CAOONL|ncf11389618
|
996
|
|
|
‡2
NKC|jx20071105024
|
996
|
|
|
‡2
CAOONL|ncf11304737
|
996
|
|
|
‡2
BNF|13838061
|
996
|
|
|
‡2
CAOONL|ncf11348282
|
996
|
|
|
‡2
DNB|143679813
|
996
|
|
|
‡2
ISNI|0000000053359149
|
996
|
|
|
‡2
J9U|987007316570605171
|
996
|
|
|
‡2
BNC|981058528538606706
|
996
|
|
|
‡2
ISNI|0000000504459182
|
996
|
|
|
‡2
LC|nb2008008964
|
996
|
|
|
‡2
J9U|987007333537305171
|
996
|
|
|
‡2
CAOONL|ncf11038142
|
996
|
|
|
‡2
BNC|981058616701106706
|
996
|
|
|
‡2
SUDOC|188987010
|
996
|
|
|
‡2
CAOONL|ncf10040120
|
996
|
|
|
‡2
NTA|393424391
|
996
|
|
|
‡2
RERO|A024587708
|
996
|
|
|
‡2
ISNI|0000000083303736
|
996
|
|
|
‡2
NTA|071131671
|
996
|
|
|
‡2
LIH|LNB:C_j__v_F;=B5
|
996
|
|
|
‡2
BIBSYS|90626969
|
996
|
|
|
‡2
CAOONL|ncf10701111
|
996
|
|
|
‡2
ISNI|0000000444415048
|
996
|
|
|
‡2
CAOONL|ncf10701114
|
996
|
|
|
‡2
ISNI|0000000367497122
|
996
|
|
|
‡2
DNB|1118419405
|
996
|
|
|
‡2
ISNI|0000000135270949
|
996
|
|
|
‡2
SUDOC|272465534
|
996
|
|
|
‡2
ISNI|0000000019831403
|
996
|
|
|
‡2
DNB|1171337965
|
996
|
|
|
‡2
ISNI|0000000049314423
|
996
|
|
|
‡2
J9U|987007326033405171
|
996
|
|
|
‡2
LC|no2019022223
|
996
|
|
|
‡2
N6I|vtls002452691
|
996
|
|
|
‡2
LC|n 77012175
|
996
|
|
|
‡2
J9U|987007329929905171
|
996
|
|
|
‡2
NDL|001207077
|
996
|
|
|
‡2
J9U|987007459845305171
|
996
|
|
|
‡2
J9U|987007355412605171
|
996
|
|
|
‡2
BNC|981058528537906706
|
996
|
|
|
‡2
SUDOC|100491928
|
996
|
|
|
‡2
LC|n 89642882
|
996
|
|
|
‡2
LC|no2011069119
|
996
|
|
|
‡2
LC|nb2011015484
|
996
|
|
|
‡2
LC|n 87103596
|
996
|
|
|
‡2
NUKAT|n 2012170658
|
996
|
|
|
‡2
LC|n 85008840
|
996
|
|
|
‡2
ISNI|0000000032145854
|
996
|
|
|
‡2
ISNI|0000000499842477
|
996
|
|
|
‡2
NII|DA0372039X
|
996
|
|
|
‡2
LC|no2004021418
|
996
|
|
|
‡2
NUKAT|n 2009051555
|
996
|
|
|
‡2
DNB|1049912810
|
996
|
|
|
‡2
ISNI|0000000059008796
|
996
|
|
|
‡2
CAOONL|ncf11280370
|
996
|
|
|
‡2
LC|n 88068059
|
996
|
|
|
‡2
DBC|87097919007065
|
996
|
|
|
‡2
LIH|LNB:BZQU;=B_e_
|
996
|
|
|
‡2
CAOONL|ncf11016966
|
996
|
|
|
‡2
LC|nb2006010918
|
996
|
|
|
‡2
LC|no2011069643
|
996
|
|
|
‡2
NUKAT|n 98047069
|
996
|
|
|
‡2
CAOONL|ncf12114430
|
996
|
|
|
‡2
NUKAT|n 2017156081
|
996
|
|
|
‡2
PLWABN|9811263828905606
|
996
|
|
|
‡2
BIBSYS|11409
|
996
|
|
|
‡2
NTA|162697759
|
996
|
|
|
‡2
ISNI|0000000420212772
|
996
|
|
|
‡2
SUDOC|074167006
|
996
|
|
|
‡2
LC|n 2006182983
|
996
|
|
|
‡2
LC|n 2016037159
|
996
|
|
|
‡2
BIBSYS|99002767
|
996
|
|
|
‡2
LC|no2023089542
|
996
|
|
|
‡2
LC|n 2019011367
|
996
|
|
|
‡2
NTA|26054034X
|
996
|
|
|
‡2
BIBSYS|2131052
|
996
|
|
|
‡2
LC|no2011067496
|
996
|
|
|
‡2
SIMACOB|213429347
|
996
|
|
|
‡2
BIBSYS|90799058
|
996
|
|
|
‡2
BNE|XX1652423
|
996
|
|
|
‡2
ISNI|0000000078062763
|
996
|
|
|
‡2
ERRR|1245025x
|
996
|
|
|
‡2
BLBNB|000375103
|
996
|
|
|
‡2
LC|nb2011000983
|
996
|
|
|
‡2
PLWABN|9810678207805606
|
996
|
|
|
‡2
PTBNP|140205
|
996
|
|
|
‡2
NII|DA19834070
|
996
|
|
|
‡2
LC|no 97054126
|
996
|
|
|
‡2
BNF|12520812
|
996
|
|
|
‡2
DNB|120587173
|
996
|
|
|
‡2
SUDOC|250760843
|
996
|
|
|
‡2
DNB|1158225113
|
996
|
|
|
‡2
RERO|A024887830
|
996
|
|
|
‡2
DNB|1066611947
|
996
|
|
|
‡2
J9U|987007339110505171
|
996
|
|
|
‡2
NTA|330169637
|
996
|
|
|
‡2
DNB|1013590724
|
996
|
|
|
‡2
NII|DA04315874
|
996
|
|
|
‡2
SUDOC|179742590
|
996
|
|
|
‡2
ISNI|0000000120161264
|
996
|
|
|
‡2
ISNI|0000000074283454
|
996
|
|
|
‡2
NTA|068806108
|
996
|
|
|
‡2
NDL|00473886
|
996
|
|
|
‡2
CAOONL|ncf10133535
|
996
|
|
|
‡2
BNF|16140663
|
996
|
|
|
‡2
SUDOC|075519992
|
996
|
|
|
‡2
NSK|000184318
|
996
|
|
|
‡2
NII|DA12807014
|
996
|
|
|
‡2
NII|DA13816010
|
996
|
|
|
‡2
SUDOC|167546376
|
996
|
|
|
‡2
VLACC|000037927
|
996
|
|
|
‡2
VLACC|000037924
|
996
|
|
|
‡2
VLACC|000037925
|
996
|
|
|
‡2
BNC|981058528538806706
|
996
|
|
|
‡2
LC|no2004021428
|
996
|
|
|
‡2
BNF|16234166
|
996
|
|
|
‡2
BNF|13517643
|
996
|
|
|
‡2
LC|n 2024048421
|
996
|
|
|
‡2
RERO|A003751951
|
996
|
|
|
‡2
RERO|A003751952
|
996
|
|
|
‡2
J9U|987007324749605171
|
996
|
|
|
‡2
SUDOC|189859202
|
996
|
|
|
‡2
CAOONL|ncf10707727
|
996
|
|
|
‡2
CAOONL|ncf10675916
|
996
|
|
|
‡2
BIBSYS|90121570
|
996
|
|
|
‡2
ISNI|0000000030795810
|
996
|
|
|
‡2
SUDOC|231688261
|
996
|
|
|
‡2
BNC|981058528538406706
|
996
|
|
|
‡2
LC|no2024100051
|
996
|
|
|
‡2
PLWABN|9810693709805606
|
996
|
|
|
‡2
BNF|17121356
|
996
|
|
|
‡2
LIH|LNB:BBJ_n_;=BS
|
996
|
|
|
‡2
J9U|987007284107105171
|
996
|
|
|
‡2
LC|n 88109880
|
996
|
|
|
‡2
CAOONL|ncf11442059
|
996
|
|
|
‡2
BNF|16513661
|
996
|
|
|
‡2
ISNI|0000000396733454
|
996
|
|
|
‡2
J9U|987007314874705171
|
996
|
|
|
‡2
SUDOC|112346340
|
996
|
|
|
‡2
N6I|vtls001288606
|
996
|
|
|
‡2
BIBSYS|90121906
|
996
|
|
|
‡2
J9U|987007458817705171
|
996
|
|
|
‡2
ISNI|0000000032031339
|
996
|
|
|
‡2
NII|DA17090245
|
996
|
|
|
‡2
NUKAT|n 95300807
|
996
|
|
|
‡2
ISNI|0000000120452790
|
996
|
|
|
‡2
LC|n 2017033014
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|